Comparison of Prostate Biopsy with or without Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Detection: An Observational Cohort Study
We hypothesized that 1) introducing prebiopsy multiparametric magnetic resonance imaging would increase the diagnostic yield of transrectal prostate biopsy and 2) this would inform recommendations regarding systematic transrectal prostate biopsy in the setting of negative prebiopsy multiparametric m...
Uloženo v:
| Vydáno v: | The Journal of urology Ročník 201; číslo 3; s. 510 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
01.03.2019
|
| Témata: | |
| ISSN: | 1527-3792, 1527-3792 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | We hypothesized that 1) introducing prebiopsy multiparametric magnetic resonance imaging would increase the diagnostic yield of transrectal prostate biopsy and 2) this would inform recommendations regarding systematic transrectal prostate biopsy in the setting of negative prebiopsy multiparametric magnetic resonance imaging.
A total of 997 biopsy naïve patients underwent transrectal prostate biopsy alone to June 2016 (cohort 1) and thereafter 792 underwent transrectal prostate biopsy following prebiopsy multiparametric magnetic resonance imaging (cohort 2). Patients with lesions on prebiopsy multiparametric magnetic resonance imaging underwent cognitive targeted plus systematic transrectal prostate biopsy. Patients without lesions underwent systematic transrectal prostate biopsy.
Cohort 2 comprised younger men (age 68 vs 69 years, p = 0.01) with lower prostate specific antigen (7.6 vs 7.9 ng/ml, p = 0.024) and smaller prostate volume (56.1 vs 62 cc, p = 0.006). In cohort 2 vs cohort 1 there was no increase in overall prostate cancer detection (57.6% vs 56.7%, p = 0.701), the Gleason Grade Group or the number of positive cores (each p >0.05). Increased multifocal prostatic intraepithelial neoplasia, maximum prostate cancer core length (5 mm or greater vs less than 5 mm) and radical surgery/high intensity focused ultrasound (each p <0.05) were observed in cohort 2. For Gleason Grade Group 2-5 prostate cancer negative prebiopsy multiparametric magnetic resonance imaging had 88.1% sensitivity, 59.8% specificity, 67.8% positive predictive value and 84% negative predictive value. For negative prebiopsy multiparametric magnetic resonance images a prostate specific antigen density cutoff of 0.15 ng/ml
or greater increased clinically significant prostate cancer detection only if the latter was defined as Gleason Grade Group 3-5 disease and/or tumor length 6 mm or greater.
Introducing prebiopsy multiparametric magnetic resonance imaging in our clinical setting increased the diagnostic yield of prostate cancer per biopsy core. Not performing a systematic transrectal prostate biopsy when prebiopsy multiparametric magnetic resonance imaging was negative would have led to under detection of 15.1% of Gleason Grade Group 2 or greater prostate cancer cases (approximately 1 in 6). |
|---|---|
| AbstractList | We hypothesized that 1) introducing prebiopsy multiparametric magnetic resonance imaging would increase the diagnostic yield of transrectal prostate biopsy and 2) this would inform recommendations regarding systematic transrectal prostate biopsy in the setting of negative prebiopsy multiparametric magnetic resonance imaging.
A total of 997 biopsy naïve patients underwent transrectal prostate biopsy alone to June 2016 (cohort 1) and thereafter 792 underwent transrectal prostate biopsy following prebiopsy multiparametric magnetic resonance imaging (cohort 2). Patients with lesions on prebiopsy multiparametric magnetic resonance imaging underwent cognitive targeted plus systematic transrectal prostate biopsy. Patients without lesions underwent systematic transrectal prostate biopsy.
Cohort 2 comprised younger men (age 68 vs 69 years, p = 0.01) with lower prostate specific antigen (7.6 vs 7.9 ng/ml, p = 0.024) and smaller prostate volume (56.1 vs 62 cc, p = 0.006). In cohort 2 vs cohort 1 there was no increase in overall prostate cancer detection (57.6% vs 56.7%, p = 0.701), the Gleason Grade Group or the number of positive cores (each p >0.05). Increased multifocal prostatic intraepithelial neoplasia, maximum prostate cancer core length (5 mm or greater vs less than 5 mm) and radical surgery/high intensity focused ultrasound (each p <0.05) were observed in cohort 2. For Gleason Grade Group 2-5 prostate cancer negative prebiopsy multiparametric magnetic resonance imaging had 88.1% sensitivity, 59.8% specificity, 67.8% positive predictive value and 84% negative predictive value. For negative prebiopsy multiparametric magnetic resonance images a prostate specific antigen density cutoff of 0.15 ng/ml
or greater increased clinically significant prostate cancer detection only if the latter was defined as Gleason Grade Group 3-5 disease and/or tumor length 6 mm or greater.
Introducing prebiopsy multiparametric magnetic resonance imaging in our clinical setting increased the diagnostic yield of prostate cancer per biopsy core. Not performing a systematic transrectal prostate biopsy when prebiopsy multiparametric magnetic resonance imaging was negative would have led to under detection of 15.1% of Gleason Grade Group 2 or greater prostate cancer cases (approximately 1 in 6). We hypothesized that 1) introducing prebiopsy multiparametric magnetic resonance imaging would increase the diagnostic yield of transrectal prostate biopsy and 2) this would inform recommendations regarding systematic transrectal prostate biopsy in the setting of negative prebiopsy multiparametric magnetic resonance imaging.PURPOSEWe hypothesized that 1) introducing prebiopsy multiparametric magnetic resonance imaging would increase the diagnostic yield of transrectal prostate biopsy and 2) this would inform recommendations regarding systematic transrectal prostate biopsy in the setting of negative prebiopsy multiparametric magnetic resonance imaging.A total of 997 biopsy naïve patients underwent transrectal prostate biopsy alone to June 2016 (cohort 1) and thereafter 792 underwent transrectal prostate biopsy following prebiopsy multiparametric magnetic resonance imaging (cohort 2). Patients with lesions on prebiopsy multiparametric magnetic resonance imaging underwent cognitive targeted plus systematic transrectal prostate biopsy. Patients without lesions underwent systematic transrectal prostate biopsy.MATERIALS AND METHODSA total of 997 biopsy naïve patients underwent transrectal prostate biopsy alone to June 2016 (cohort 1) and thereafter 792 underwent transrectal prostate biopsy following prebiopsy multiparametric magnetic resonance imaging (cohort 2). Patients with lesions on prebiopsy multiparametric magnetic resonance imaging underwent cognitive targeted plus systematic transrectal prostate biopsy. Patients without lesions underwent systematic transrectal prostate biopsy.Cohort 2 comprised younger men (age 68 vs 69 years, p = 0.01) with lower prostate specific antigen (7.6 vs 7.9 ng/ml, p = 0.024) and smaller prostate volume (56.1 vs 62 cc, p = 0.006). In cohort 2 vs cohort 1 there was no increase in overall prostate cancer detection (57.6% vs 56.7%, p = 0.701), the Gleason Grade Group or the number of positive cores (each p >0.05). Increased multifocal prostatic intraepithelial neoplasia, maximum prostate cancer core length (5 mm or greater vs less than 5 mm) and radical surgery/high intensity focused ultrasound (each p <0.05) were observed in cohort 2. For Gleason Grade Group 2-5 prostate cancer negative prebiopsy multiparametric magnetic resonance imaging had 88.1% sensitivity, 59.8% specificity, 67.8% positive predictive value and 84% negative predictive value. For negative prebiopsy multiparametric magnetic resonance images a prostate specific antigen density cutoff of 0.15 ng/ml2 or greater increased clinically significant prostate cancer detection only if the latter was defined as Gleason Grade Group 3-5 disease and/or tumor length 6 mm or greater.RESULTSCohort 2 comprised younger men (age 68 vs 69 years, p = 0.01) with lower prostate specific antigen (7.6 vs 7.9 ng/ml, p = 0.024) and smaller prostate volume (56.1 vs 62 cc, p = 0.006). In cohort 2 vs cohort 1 there was no increase in overall prostate cancer detection (57.6% vs 56.7%, p = 0.701), the Gleason Grade Group or the number of positive cores (each p >0.05). Increased multifocal prostatic intraepithelial neoplasia, maximum prostate cancer core length (5 mm or greater vs less than 5 mm) and radical surgery/high intensity focused ultrasound (each p <0.05) were observed in cohort 2. For Gleason Grade Group 2-5 prostate cancer negative prebiopsy multiparametric magnetic resonance imaging had 88.1% sensitivity, 59.8% specificity, 67.8% positive predictive value and 84% negative predictive value. For negative prebiopsy multiparametric magnetic resonance images a prostate specific antigen density cutoff of 0.15 ng/ml2 or greater increased clinically significant prostate cancer detection only if the latter was defined as Gleason Grade Group 3-5 disease and/or tumor length 6 mm or greater.Introducing prebiopsy multiparametric magnetic resonance imaging in our clinical setting increased the diagnostic yield of prostate cancer per biopsy core. Not performing a systematic transrectal prostate biopsy when prebiopsy multiparametric magnetic resonance imaging was negative would have led to under detection of 15.1% of Gleason Grade Group 2 or greater prostate cancer cases (approximately 1 in 6).CONCLUSIONSIntroducing prebiopsy multiparametric magnetic resonance imaging in our clinical setting increased the diagnostic yield of prostate cancer per biopsy core. Not performing a systematic transrectal prostate biopsy when prebiopsy multiparametric magnetic resonance imaging was negative would have led to under detection of 15.1% of Gleason Grade Group 2 or greater prostate cancer cases (approximately 1 in 6). |
| Author | Shields, William Hobbs, Catherine P Bryant, Richard J MacPherson, Ruth E Davies, Lucy C Sooriakumaran, Prasanna Gleeson, Fergus V Hamdy, Freddie C Verrill, Clare L Brewster, Simon F Sullivan, Mark E Eyre, Katie S |
| Author_xml | – sequence: 1 givenname: Richard J surname: Bryant fullname: Bryant, Richard J organization: Nuffield Departments of Surgical Sciences, University of Oxford , Oxford , United Kingdom – sequence: 2 givenname: Catherine P surname: Hobbs fullname: Hobbs, Catherine P organization: Department of Urology, Oxford University Hospitals National Health Service Foundation Trust, University of Oxford , Oxford , United Kingdom – sequence: 3 givenname: Katie S surname: Eyre fullname: Eyre, Katie S organization: Department of Urology, Oxford University Hospitals National Health Service Foundation Trust, University of Oxford , Oxford , United Kingdom – sequence: 4 givenname: Lucy C surname: Davies fullname: Davies, Lucy C organization: Nuffield Departments of Population Health, University of Oxford , Oxford , United Kingdom – sequence: 5 givenname: Mark E surname: Sullivan fullname: Sullivan, Mark E organization: Department of Urology, Oxford University Hospitals National Health Service Foundation Trust, University of Oxford , Oxford , United Kingdom – sequence: 6 givenname: William surname: Shields fullname: Shields, William organization: Department of Urology, Oxford University Hospitals National Health Service Foundation Trust, University of Oxford , Oxford , United Kingdom – sequence: 7 givenname: Prasanna surname: Sooriakumaran fullname: Sooriakumaran, Prasanna organization: Department of Uro-Oncology, University College London Hospital National Health Service Foundation Trust , London , United Kingdom – sequence: 8 givenname: Clare L surname: Verrill fullname: Verrill, Clare L organization: Nuffield Departments of Surgical Sciences, University of Oxford , Oxford , United Kingdom – sequence: 9 givenname: Fergus V surname: Gleeson fullname: Gleeson, Fergus V organization: Department of Radiology, Oxford University Hospitals National Health Service Foundation Trust, University of Oxford , Oxford , United Kingdom – sequence: 10 givenname: Ruth E surname: MacPherson fullname: MacPherson, Ruth E organization: Department of Radiology, Oxford University Hospitals National Health Service Foundation Trust, University of Oxford , Oxford , United Kingdom – sequence: 11 givenname: Freddie C surname: Hamdy fullname: Hamdy, Freddie C organization: Nuffield Departments of Surgical Sciences, University of Oxford , Oxford , United Kingdom – sequence: 12 givenname: Simon F surname: Brewster fullname: Brewster, Simon F organization: Department of Urology, Oxford University Hospitals National Health Service Foundation Trust, University of Oxford , Oxford , United Kingdom |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30266332$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkEtPGzEUha0KVAjlD3RRedlNpn7Mszs6lIdEFERhHd2xr4OjGTu1PVT5NfzVToCirs65Oud-izMjB847JOQzZxlnvPy2yTZj8JlgvM5Yk7G8-UCOeSGquawacfCfPyKzGDeM8byoxEdyJJkoSynFMXlu_bCFYKN31Bt6G3xMkJD-sH4bd_SPTY_Uhxf1Y5py7F6TxdgnO33CgClYRRewdpgmc4cTC5xCej3A2ro1NRPgHdzuo0DPMaFK1rvv9MzRZRcxPMH-hp62_tGHRH-lUe8-kUMDfcTTNz0hDxc_79ur-c3y8ro9u5kryWSa50UNRhlVK4maY5cXvOqgNHkBoHRemrLoRGlAaq2xZo3WvDOylgXUWuWiEifk6yt3G_zvEWNaDTYq7Htw6Me4EpznZSM531e_vFXHbkC92gY7QNit_o0q_gIEt4ET |
| CitedBy_id | crossref_primary_10_1111_bju_15978 crossref_primary_10_1007_s00261_021_03179_5 crossref_primary_10_1148_radiol_2019182946 crossref_primary_10_1002_pros_24669 crossref_primary_10_1007_s00092_019_2059_7 crossref_primary_10_1016_j_eururo_2018_12_031 crossref_primary_10_1016_S1470_2045_25_00100_7 crossref_primary_10_1111_bju_15355 crossref_primary_10_1016_j_urolonc_2021_12_016 crossref_primary_10_1097_CCO_0000000000000625 crossref_primary_10_1177_2051415820932773 crossref_primary_10_1016_j_eururo_2020_03_048 crossref_primary_10_1111_bju_15093 crossref_primary_10_1002_prca_202000025 crossref_primary_10_1002_cnr2_1668 crossref_primary_10_1177_20514158211059057 crossref_primary_10_1016_j_euros_2021_03_008 crossref_primary_10_1515_med_2024_1048 crossref_primary_10_1186_s13063_024_08224_4 crossref_primary_10_3389_fonc_2022_973285 crossref_primary_10_1038_s41391_021_00330_7 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.juro.2018.09.049 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1527-3792 |
| ExternalDocumentID | 30266332 |
| Genre | Journal Article Comparative Study Observational Study |
| GrantInformation_xml | – fundername: Cancer Research UK grantid: 22748 |
| GroupedDBID | --- --K .55 .GJ .XZ 08P 0R~ 123 1B1 1CY 354 3O- 4.4 457 4G. 4Q1 4Q2 4Q3 53G 5RE 5VS 7-5 AAAAV AAEDT AAEDW AAGIX AAHPQ AAIQE AAJCS AAKAS AALRI AAMOA AAQFI AAQKA AAQQT AAQXK AASCR AASXQ AAXUO ABASU ABCQX ABDIG ABJNI ABLJU ABMAC ABOCM ABPPZ ABPXF ABVCZ ABWVN ABXYN ABZZY ACGFS ACILI ACLDA ACOAL ACRPL ACVFH ACXJB ACZKN ADCNI ADGGA ADGHP ADHPY ADMUD ADNKB ADNMO ADZCM AEBDS AEETU AENEX AFBFQ AFDTB AFEXH AFFNX AFNMH AFTRI AFUWQ AGHFR AGQPQ AHOMT AHQNM AHQVU AHRYX AHVBC AI. AIGII AINUH AITUG AIZYK AJCLO AJIOK AJNWD AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AMRAJ AOQMC ASGHL ASPBG AVWKF AZFZN BCGUY BELOY BYPQX C45 C5W CGR CS3 CUY CVF DIWNM DU5 EBS ECM EEVPB EIF EJD ERAAH EX3 F5P FCALG FDB FEDTE FGOYB GBLVA GNXGY GQDEL HLJTE HVGLF HZ~ H~9 IH2 IHE IKREB IKYAY IPNFZ J5H KMI L7B M41 MJL MO0 N4W NPM NQ- NTWIH O9- OAG OAH OB3 OBH ODMTH OGROG OHH OL1 OVD OWU OWV OWW OWY OWZ P2P QTD R2- RIG RLZ ROL RPZ SEL SES SJN SSZ TEORI TSPGW UDS UNMZH UV1 VH1 VVN WOW X7M XH2 XYM YFH YOC ZCG ZFV ZGI ZXP ZY1 ZZMQN 7X8 ACBKD ADKSD ADSXY |
| ID | FETCH-LOGICAL-c303t-458afcfc8c3ed1eb4517ba6f45aacd46f65b26fa3ddde809dd1bf3835a8dc4272 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 27 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000475762000036&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1527-3792 |
| IngestDate | Sun Nov 09 10:52:40 EST 2025 Mon Jul 21 06:08:08 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | biopsy diagnosis prostate specific antigen magnetic resonance imaging prostatic neoplasms |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c303t-458afcfc8c3ed1eb4517ba6f45aacd46f65b26fa3ddde809dd1bf3835a8dc4272 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
| PMID | 30266332 |
| PQID | 2114693117 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2114693117 pubmed_primary_30266332 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-03-00 20190301 |
| PublicationDateYYYYMMDD | 2019-03-01 |
| PublicationDate_xml | – month: 03 year: 2019 text: 2019-03-00 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | The Journal of urology |
| PublicationTitleAlternate | J Urol |
| PublicationYear | 2019 |
| References | 30759693 - J Urol. 2019 Mar;201(3):518. doi: 10.1097/01.JU.0000553709.74021.24. |
| References_xml | – reference: 30759693 - J Urol. 2019 Mar;201(3):518. doi: 10.1097/01.JU.0000553709.74021.24. |
| SSID | ssj0014572 |
| Score | 2.4256916 |
| Snippet | We hypothesized that 1) introducing prebiopsy multiparametric magnetic resonance imaging would increase the diagnostic yield of transrectal prostate biopsy and... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 510 |
| SubjectTerms | Aged Biopsy Cohort Studies Humans Magnetic Resonance Imaging Male Preoperative Period Prostate - diagnostic imaging Prostate - pathology Prostatic Neoplasms - diagnostic imaging Prostatic Neoplasms - pathology |
| Title | Comparison of Prostate Biopsy with or without Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Detection: An Observational Cohort Study |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/30266332 https://www.proquest.com/docview/2114693117 |
| Volume | 201 |
| WOSCitedRecordID | wos000475762000036&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JTsMwELWAIsSFfV9kJK4ROHYWc0GlUMGhpQeQeqtsx2aRSEraIvE1_CozTkpvCIlLchglsuyZ8eyPkFPDMgfnrIM4FuCgSJA5zRQYcsIaF8VWpLwCm0i63bTfl7064DaqyyqnOtEr6qwwGCM_C7F9VnLGksvhe4CoUZhdrSE05kmDgymDXJ30Z1kEEXnwJkRuBUGSYd00U9V3vU5KbP5jqZ9zKn4xMf1V01797yLXyEptZNJmxRXrZM7mG2SpU6fRN8lX6wd9kBaO9rDzA2xOevVSDEefFGOztCj9u5iMgW51RfHtujgt_A2BuAztqKccuyApZgFwdIeld28e94iCMTz7cQtJJb22Y1_5lV_QZk7v9U9EGBbbKp7BE6BY1_i5RR7bNw-t26BGaggMXIHjQESpcsaZ1HCbMatFxBKtYicipUwmYhdHOoyd4hlo0_RcZhnTDnzjSKWZEWESbpOFvMjtLqFWCMWkdiaUWjhw79JQM1BDiZLgrHO7R06mWz8AScD0hsptMRkNZpu_R3aq8xsMq5EdAw6uZsx5uP-Hrw_IMrCFrArNDknDgR6wR2TRfIxfRuWxZzF4dnudbwwZ324 |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+Prostate+Biopsy+with+or+without+Prebiopsy+Multiparametric+Magnetic+Resonance+Imaging+for+Prostate+Cancer+Detection%3A+An+Observational+Cohort+Study&rft.jtitle=The+Journal+of+urology&rft.au=Bryant%2C+Richard+J&rft.au=Hobbs%2C+Catherine+P&rft.au=Eyre%2C+Katie+S&rft.au=Davies%2C+Lucy+C&rft.date=2019-03-01&rft.eissn=1527-3792&rft.volume=201&rft.issue=3&rft.spage=510&rft_id=info:doi/10.1016%2Fj.juro.2018.09.049&rft_id=info%3Apmid%2F30266332&rft_id=info%3Apmid%2F30266332&rft.externalDocID=30266332 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1527-3792&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1527-3792&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1527-3792&client=summon |